Related Experiment Video
Updated: May 19, 2026

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Modulating Cardiac-Gut Microbiome Interaction Post-Myocardial Infarction with Engineered Bacteria
Abstract:
The gut microbiome plays a critical role in the pathophysiology of acute myocardial infarction (MI). MI events significantly impact intestinal integrity which results in leakage of bacterial products into the systemic circulation. We demonstrate that MI not only compromises intestinal integrity, leading to systemic leakage of bacterial products like LPS, but also results in the translocation and colonization of live, intact gut bacteria in the MI heart - a novel aspect of the heart-gut axis. Our initial findings with natural murine gut microbiome were substantiated using orally administered E. coli Nissle 1917 (EcN), as a tracer bacterium. Furthermore, we engineered EcN to express the microbial anti-inflammatory molecule (MAM) derived from the probiotic Faecalibacterium prausnitzii . Treatment with this engineered strain, EcN-MAM, led to significantly improved survival and cardiac function in MI mice. This was attributed to enhanced gut barrier integrity, resulting in reduced systemic bacterial permeation and subsequent inflammation. These findings shed light on a previously unrecognized dimension of the heart-gut axis and highlight the potential of microbiome-based interventions in MI management.
Insights
Myocardial infarction (MI) compromises gut integrity, allowing gut bacteria to enter the heart. Engineered bacteria delivering anti-inflammatory molecules improved survival and cardiac function in MI mice.
Area of Science:
- Cardiovascular Research
- Microbiome Research
- Gastroenterology
Background:
- The gut microbiome is crucial in acute myocardial infarction (MI) pathophysiology.
- MI compromises intestinal integrity, leading to systemic leakage of bacterial products.
- A novel heart-gut axis involves gut bacteria translocating to the MI heart.
Purpose of the Study:
- To investigate the impact of MI on gut integrity and bacterial translocation.
- To explore the therapeutic potential of engineered gut bacteria in MI.
- To elucidate the role of the heart-gut axis in MI recovery.
Main Methods:
- Utilized a murine model of acute myocardial infarction.
- Administered orally E. coli Nissle 1917 (EcN) as a tracer bacterium.
- Engineered EcN to express a microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii.
Main Results:
- MI led to compromised gut integrity and systemic leakage of bacterial products.
- Live gut bacteria were found translocated and colonized in the MI heart.
- Treatment with engineered EcN-MAM improved survival and cardiac function in MI mice.
- EcN-MAM enhanced gut barrier integrity, reducing systemic bacterial permeation and inflammation.
Conclusions:
- MI induces a novel heart-gut axis involving bacterial translocation to the heart.
- Engineered microbiome-based therapies show promise for MI management.
- Targeting the heart-gut axis may offer new therapeutic strategies for cardiovascular diseases.
More Related Videos
Related Concept Videos
Functions of the Gut Microbiota
Gut-Brain Axis
Microbiota of the Large Intestine
Probiotics
Microbiota of the Stomach and Small Intestine
What is Monogastric Digestion?

